Skip to main content
logo
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
24.92
+0.14 (0.56%)
Sep 2, 2026, 11:45 AM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Molecular Profiling Services Revenue
952.77M766.72M349.12M
Pharma Research and Development Services Revenue
36.84M45.31M63.15M
Revenue (Total)
989.61M812.03M412.26M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States Revenue
980.19M801.39M401.84M
International Revenue
9.42M10.64M10.42M
Revenue (Total)
989.61M812.03M412.26M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Molecular Intelligence (MI) Profile - Clinical Case Volume
179.28K170.30K146.60K
Caris Assure - Clinical Case Volume
35.99K29.00K16.30K
Total Clinical Case Volume
215.46K199.30K162.90K
Molecular Intelligence (MI) Profile - Clinical Average Selling Price (ASP)
-4.03K2.20K
Caris Assure - Clinical Average Selling Price (ASP)
-2.80K1.65K